• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2000 - 2010年的结核病:得到了控制,但未被消灭。

Tuberculosis 2000-2010: control, but not elimination.

作者信息

Dye C

机构信息

Communicable Diseases Control, Prevention & Eradication, World Health Organization, Geneva, Switzerland.

出版信息

Int J Tuberc Lung Dis. 2000 Dec;4(12 Suppl 2):S146-52.

PMID:11144545
Abstract

The main task of global tuberculosis (TB) control over the next decade is to dramatically reduce TB deaths, the average duration of illness, and incidence--in that order. The best possible application of chemotherapy has the potential to cut the TB burden by more than 50% in 10 years. Mass screening for active TB has not generally been recommended, but the costs and benefits of targeted active case finding deserve further investigation. Among potential new tools for TB control, the biggest prize would be a high-efficacy vaccine that can produce long-lasting immunity. Now that good control programmes are becoming more widespread, new methods and indicators are needed to evaluate epidemiological impact. Even if morbidity and mortality are significantly reduced before 2010, tuberculosis infection will persist for much longer, acting as a sensitive indicator of public health, and as a marker of the quality of health services.

摘要

未来十年全球结核病控制的主要任务是依次大幅降低结核病死亡人数、疾病平均持续时间和发病率。化疗的最佳应用有可能在10年内将结核病负担降低50%以上。一般不建议进行大规模活动性结核病筛查,但针对性主动病例发现的成本效益值得进一步研究。在结核病控制的潜在新工具中,最大的收获将是一种能产生持久免疫力的高效疫苗。鉴于良好的控制方案正日益普及,需要新的方法和指标来评估流行病学影响。即使在2010年前发病率和死亡率显著降低,结核感染仍将持续更长时间,它是公共卫生的敏感指标,也是卫生服务质量的标志。

相似文献

1
Tuberculosis 2000-2010: control, but not elimination.2000 - 2010年的结核病:得到了控制,但未被消灭。
Int J Tuberc Lung Dis. 2000 Dec;4(12 Suppl 2):S146-52.
2
[Reform of Japan's NTP and its technical perspectives].[日本国家毒理学计划的改革及其技术视角]
Kekkaku. 2004 Oct;79(10):587-604.
3
[Development of antituberculous drugs: current status and future prospects].[抗结核药物的研发:现状与未来前景]
Kekkaku. 2006 Dec;81(12):753-74.
4
[Tuberculosis and its control--lessons from the past and future prospect].[结核病及其防治——历史经验与未来展望]
Kekkaku. 2005 Jun;80(6):481-9.
5
Global epidemiology of tuberculosis: prospects for control.全球结核病流行病学:控制前景
Semin Respir Crit Care Med. 2008 Oct;29(5):481-91. doi: 10.1055/s-0028-1085700. Epub 2008 Sep 22.
6
The management for tuberculosis control in Greater London in comparison with that in Osaka City: lessons for improvement of TB control management in Osaka City urban setting.大伦敦地区与大阪市结核病控制管理的比较:大阪市城市环境中结核病控制管理改进的经验教训
Health Policy. 2005 Jul;73(1):104-23. doi: 10.1016/j.healthpol.2004.11.006. Epub 2004 Dec 13.
7
Highly active antiretroviral therapy and tuberculosis control in Africa: synergies and potential.非洲的高效抗逆转录病毒疗法与结核病控制:协同作用与潜力
Bull World Health Organ. 2002;80(6):464-9.
8
The Global TB Drug Facility: innovative global procurement.全球结核病药物基金:创新性全球采购。
Int J Tuberc Lung Dis. 2004 Jan;8(1):130-8.
9
An evaluation of the tuberculosis control programme of Selangor State, Malaysia for the year 2001.2001年马来西亚雪兰莪州结核病控制项目评估
Med J Malaysia. 2004 Mar;59(1):20-5.
10
[Amendment of tuberculosis prevention law and prospect of tuberculosis control program].[结核病预防法的修订与结核病控制规划的前景]
Kekkaku. 2005 Jul;80(7):541-6.

引用本文的文献

1
Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.在坦桑尼亚姆万扎,采用 QuantiFERON-TB Gold assay 和 ESAT-6 free IGRA 检测青少年结核分枝杆菌感染的流行率。
PLoS One. 2021 Jun 7;16(6):e0252808. doi: 10.1371/journal.pone.0252808. eCollection 2021.
2
Time to death and risk factors among tuberculosis patients in Northern Ethiopia.埃塞俄比亚北部结核病患者的死亡时间及危险因素。
BMC Res Notes. 2018 Oct 4;11(1):696. doi: 10.1186/s13104-018-3806-7.
3
The global burden of tuberculosis: results from the Global Burden of Disease Study 2015.
全球结核病负担:来自 2015 年全球疾病负担研究的结果。
Lancet Infect Dis. 2018 Mar;18(3):261-284. doi: 10.1016/S1473-3099(17)30703-X. Epub 2017 Dec 7.
4
Systematic review of mathematical models exploring the epidemiological impact of future TB vaccines.探索未来结核病疫苗流行病学影响的数学模型系统评价。
Hum Vaccin Immunother. 2016 Nov;12(11):2813-2832. doi: 10.1080/21645515.2016.1205769. Epub 2016 Jul 22.
5
Factors associated with tuberculosis cases in Semarang District, Indonesia: case-control study performed in the area where case detection rate was extremely low.印度尼西亚三宝垄市结核病病例相关因素:在病例检出率极低地区开展的病例对照研究
Environ Health Prev Med. 2015 Jul;20(4):253-61. doi: 10.1007/s12199-015-0443-9. Epub 2015 Apr 16.
6
Transmissibility of tuberculosis among school contacts: an outbreak investigation in a boarding middle school, China.学校接触者中结核病的传播:中国一所寄宿制中学的暴发调查
Infect Genet Evol. 2015 Jun;32:148-55. doi: 10.1016/j.meegid.2015.03.001. Epub 2015 Mar 7.
7
Protective capacity of proteoliposomes from Mycobacterium bovis BCG in a mouse model of tuberculosis.牛分枝杆菌卡介苗蛋白脂质体在小鼠结核病模型中的保护能力
Hum Vaccin Immunother. 2015;11(3):657-61. doi: 10.1080/21645515.2015.1011566.
8
In silico identification of common epitopes from pathogenic mycobacteria.计算机预测病原分枝杆菌共同表位。
BMC Immunol. 2013;14 Suppl 1(Suppl 1):S6. doi: 10.1186/1471-2172-14-S1-S6. Epub 2013 Feb 25.
9
Immunogenicity of recombinant Mycobacterium bovis bacille Calmette-Guèrin clones expressing T and B cell epitopes of Mycobacterium tuberculosis antigens.表达结核分枝杆菌抗原 T 和 B 细胞表位的重组牛分枝杆菌卡介苗克隆的免疫原性。
BMC Immunol. 2013;14 Suppl 1(Suppl 1):S5. doi: 10.1186/1471-2172-14-S1-S5. Epub 2013 Feb 25.
10
Strategies for potentiation of ethionamide and folate antagonists against Mycobacterium tuberculosis.增强乙胺丁醇和叶酸拮抗剂对结核分枝杆菌作用的策略。
Expert Rev Anti Infect Ther. 2012 Sep;10(9):971-81. doi: 10.1586/eri.12.87.